Product catalog
contact us

    KCI BioTech (Suzhou) Inc.
    Tel:0512-69998806
    Ministry of Commerce:0512-69998806-8012
    BD:
    East and South China:Ms. Gu 15378638068
    North China, East China:Mr. Han 18914988667
    Central and Western regions: Ms. Xiang 15828112963
    Project Management Department:0512-69998806-8022
    Tumor business:0512-69998806-8058
    Non tumor business:0512-69998806-8026
    Pathogenic microorganism business:0512-69998806-8037
    Integrated Service Platform:0512-69998806-8022
    Address: Building A2, Xinyang Industrial Park, No. 8 Yanghua Road, Suzhou Industrial Park

Key Models for cerebral palsy Drug Development

Cerebral palsy (cerebral palsy), the full name is cerebral palsy. Cerebral palsy is a syndrome of non-progressive brain injury that occurs during the early stages of brain development from before birth to one month after birth, due to a variety of reasons. Cerebral palsy is one of the major diseases that cause motor disability in children, mainly manifested by central motor disorder and postural abnormality, which may also be accompanied by mental retardation, epilepsy, sensory and perceptual disorders, language disorders, and mental and behavioral abnormalities.
  We have established a stable hypoxia-induced cerebral palsy model, which is suitable for preclinical research and evaluation of new drugs for the treatment of cerebral palsy.
  If you have a project need and experience more of our professional services, please contact us.

Our Services

Model classification

Model Name

Animal species

cerebral palsy

Low oxygen induced cerebral palsy model

Rat

Case sharing

Previous:Nothing
Next:Pain disorder